Muutke küpsiste eelistusi

E-raamat: Diabetes and COVID-19: Considerations and Clinical Management

Edited by
  • Formaat: PDF+DRM
  • Sari: Contemporary Endocrinology
  • Ilmumisaeg: 10-Jun-2023
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783031285363
  • Formaat - PDF+DRM
  • Hind: 111,14 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Sari: Contemporary Endocrinology
  • Ilmumisaeg: 10-Jun-2023
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783031285363

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.

Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions. 

COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.

Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY